Role of Pulmonary Function in Predicting New-Onset Cardiometabolic Diseases and Cardiometabolic Multimorbidity

医学 内科学 多发病率 心脏病学 肺功能测试 重症监护医学 共病
作者
Guochen Li,Yanqiang Lu,Yanan Qiao,Die Hu,Chaofu Ke
出处
期刊:Chest [Elsevier BV]
卷期号:162 (2): 421-432 被引量:28
标识
DOI:10.1016/j.chest.2021.12.663
摘要

Although pulmonary function has been studied in relationship to individual cardiometabolic diseases, uncertainty persists about the difference in risk magnitudes of pulmonary function for these diseases and its association with cardiometabolic multimorbidity (CM).Does pulmonary function have different risk magnitudes for cardiometabolic diseases and CM?This study used data from the UK Biobank, including 357,433 individuals with no cardiometabolic diseases at baseline (stage I) and 35,034 individuals with one cardiometabolic disease at baseline (stage II). Pulmonary function was measured by FVC or FEV1. We defined CM as the coexistence of at least two cardiometabolic diseases: type 2 diabetes (T2D), coronary heart disease (CHD), and stroke. Multinomial logistic regression models and Cox proportional hazards models were performed to estimate ORs or hazard ratios (HRs) and their 95% CIs for the longitudinal relationship between baseline pulmonary function and incident cardiometabolic outcomes.In stage I, FVC showed the most pronounced associations with new-onset CM and T2D among the four mutually exclusive end points. Compared with the lowest quartile (quartile 1), the adjusted ORs of quartile 4 of FVC were 0.525 (95% CI, 0.468-0.589) for CM, 0.534 (95% CI, 0.498-0.572) for T2D alone, 0.817 (95% CI, 0.751-0.888) for stroke alone, and 0.800 (95% CI, 0.764-0.837) for CHD alone. In stage II, FVC also was associated with the risk of CM in patients with T2D (HR of quartile 4, 0.727; 95% CI, 0.649-0.814), patients with CHD (HR, 0.635; 95% CI, 0.555-0.727), and patients who experienced stroke (HR, 0.783, 95% CI, 0.642-0.955). Similar results were observed for FEV1 in both stages.This study revealed the different risk associations of pulmonary function with individual cardiometabolic diseases and CM. Tailor-made screening and monitoring through pulmonary function may be applicable for the precise prevention and control of these conditions.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
甜甜蜜蜜小白周完成签到 ,获得积分10
1秒前
射天狼完成签到,获得积分10
2秒前
bkagyin应助whaoe采纳,获得10
2秒前
其实是北北吖完成签到,获得积分10
3秒前
3秒前
儒雅水池完成签到 ,获得积分10
4秒前
MMTI完成签到,获得积分10
4秒前
J18完成签到,获得积分10
5秒前
七龙珠完成签到,获得积分10
7秒前
无辜听兰应助跳跃的鱼采纳,获得10
7秒前
尘曦完成签到,获得积分10
7秒前
user20011125完成签到 ,获得积分10
8秒前
Enquinn完成签到,获得积分10
8秒前
lizishu给高立蕊的求助进行了留言
10秒前
石林完成签到,获得积分10
11秒前
青青完成签到,获得积分10
13秒前
林千万完成签到,获得积分10
14秒前
14秒前
前程似锦完成签到 ,获得积分10
14秒前
15秒前
revew666完成签到,获得积分10
16秒前
大方的慕青完成签到,获得积分10
16秒前
将爱却晚秋完成签到,获得积分10
17秒前
17秒前
梁平完成签到 ,获得积分10
18秒前
苗儿发布了新的文献求助30
19秒前
nexus应助科研通管家采纳,获得10
19秒前
慕青应助科研通管家采纳,获得10
19秒前
华仔应助科研通管家采纳,获得10
19秒前
跳跃的鱼完成签到,获得积分10
19秒前
科研通AI2S应助科研通管家采纳,获得10
19秒前
19秒前
麻花阳应助科研通管家采纳,获得10
19秒前
安静的嘚嘚完成签到 ,获得积分10
19秒前
19秒前
念之完成签到 ,获得积分10
20秒前
彪壮的绮烟完成签到,获得积分10
20秒前
高大的阑香完成签到,获得积分10
21秒前
21秒前
贪玩初彤完成签到 ,获得积分10
21秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
AnnualResearch andConsultation Report of Panorama survey and Investment strategy onChinaIndustry 1000
卤化钙钛矿人工突触的研究 1000
Engineering for calcareous sediments : proceedings of the International Conference on Calcareous Sediments, Perth 15-18 March 1988 / edited by R.J. Jewell, D.C. Andrews 1000
Continuing Syntax 1000
Signals, Systems, and Signal Processing 610
2026 Hospital Accreditation Standards 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6262843
求助须知:如何正确求助?哪些是违规求助? 8084887
关于积分的说明 16891997
捐赠科研通 5333349
什么是DOI,文献DOI怎么找? 2839003
邀请新用户注册赠送积分活动 1816435
关于科研通互助平台的介绍 1670192